277 related articles for article (PubMed ID: 7597787)
1. Molecular basis for vaccine development against anaplasmosis and babesiosis.
Palmer GH; McElwain TF
Vet Parasitol; 1995 Mar; 57(1-3):233-53. PubMed ID: 7597787
[TBL] [Abstract][Full Text] [Related]
2. Immunization of cattle with an inactivated polyvalent vaccine against anaplasmosis and babesiosis.
Montenegro-James S; Toro M; Leon E; Guillen AT; Lopez R; Lopez W
Ann N Y Acad Sci; 1992 Jun; 653():112-21. PubMed ID: 1626861
[No Abstract] [Full Text] [Related]
3. Attenuated trivalent vaccine against babesiosis and anaplasmosis in Colombia.
Benavides E; Vizcaino O; Britto CM; Romero A; Rubio A
Ann N Y Acad Sci; 2000; 916():613-6. PubMed ID: 11193685
[No Abstract] [Full Text] [Related]
4. Emerging perspectives in the research of bovine babesiosis and anaplasmosis.
Suarez CE; Noh S
Vet Parasitol; 2011 Aug; 180(1-2):109-25. PubMed ID: 21684084
[TBL] [Abstract][Full Text] [Related]
5. The safety and efficacy of Australian tick-borne disease vaccine strains in cattle in Paraguay.
Brizuela CM; Ortellado CA; Sanabria E; Torres O; Ortigosa D
Vet Parasitol; 1998 Mar; 76(1-2):27-41. PubMed ID: 9653988
[TBL] [Abstract][Full Text] [Related]
6. Prospects for subunit vaccines against tick-borne diseases.
Musoke AJ; Palmer GH; McElwain TF; Nene V; McKeever D
Br Vet J; 1996 Nov; 152(6):621-39. PubMed ID: 8979421
[TBL] [Abstract][Full Text] [Related]
7. Subunit vaccines for complex tick-borne pathogens: dream or reality?
Morrison WI
Br Vet J; 1996 Nov; 152(6):617-9. PubMed ID: 8979420
[No Abstract] [Full Text] [Related]
8. Immunity following use of Australian tick fever vaccine: a review of the evidence.
Bock RE; de Vos AJ
Aust Vet J; 2001 Dec; 79(12):832-9. PubMed ID: 11837905
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a frozen trivalent attenuated vaccine against Babesiosis and anaplasmosis in Brazil.
Vidotto O; Barbosa CS; Andrade GM; Machado RZ; da Rocha MA; Silva SS
Ann N Y Acad Sci; 1998 Jun; 849():420-3. PubMed ID: 9668502
[No Abstract] [Full Text] [Related]
10. Immunodiagnosis of and immunoprophylaxis against the haemoparasites Babesia sp. and Anaplasma sp. in domestic animals.
Wright IG
Rev Sci Tech; 1990 Jun; 9(2):345-56. PubMed ID: 2132684
[TBL] [Abstract][Full Text] [Related]
11. Live vaccines against hemoparasitic diseases in livestock.
Pipano E
Vet Parasitol; 1995 Mar; 57(1-3):213-31. PubMed ID: 7597786
[TBL] [Abstract][Full Text] [Related]
12. Immunisation of smallholder dairy cattle against anaplasmosis and babesiosis in Malawi.
Tjornehoj K; Lawrence JA; Kafuwa PT; Whiteland AP; Chimera BA
Trop Anim Health Prod; 1997 May; 29(2):77-82. PubMed ID: 9203307
[TBL] [Abstract][Full Text] [Related]
13. Tick-borne diseases of cattle in Paraguay. II. Immunisation against anaplasmosis and babesiosis.
Payne RC; Osorio O; Ybañez A
Trop Anim Health Prod; 1990 May; 22(2):101-8. PubMed ID: 2196724
[TBL] [Abstract][Full Text] [Related]
14. Post-thawing viability of vaccines for bovine babesiosis and anaplasmosis cryopreserved with glycerol.
Mangold AJ; Aguirre DH; Guglielmone AA
Vet Parasitol; 1990 Nov; 37(3-4):301-6. PubMed ID: 2267730
[TBL] [Abstract][Full Text] [Related]
15. Prospects for recombinant vaccines against Babesia bovis and related parasites.
Brown WC; Norimine J; Goff WL; Suarez CE; McElwain TF
Parasite Immunol; 2006 Jul; 28(7):315-27. PubMed ID: 16842268
[TBL] [Abstract][Full Text] [Related]
16. Serological evidence of exposure to tick fever organisms in young cattle on Queensland dairy farms.
Sserugga JN; Jonsson NN; Bock RE; More SJ
Aust Vet J; 2003 Mar; 81(3):147-52. PubMed ID: 15080428
[TBL] [Abstract][Full Text] [Related]
17. Assessment of tetracycline and Babesia culture supernatant as prophylactics for moderating reactions in cattle to live Babesia and Anaplasma vaccines.
Jorgensen WK; Bock RE; Kingston TG; de Vos AJ; Waldron SJ
Aust Vet J; 1993 Jan; 70(1):35-6. PubMed ID: 8460988
[No Abstract] [Full Text] [Related]
18. Immunisation of cattle against Babesia bovis combining a multi-epitope modified vaccinia Ankara virus and a recombinant protein induce strong Th1 cell responses but fails to trigger neutralising antibodies required for protection.
Jaramillo Ortiz JM; Paoletta MS; Gravisaco MJ; López Arias LS; Montenegro VN; de la Fournière SAM; Valenzano MN; Guillemi EC; Valentini B; Echaide I; Farber MD; Wilkowsky SE
Ticks Tick Borne Dis; 2019 Oct; 10(6):101270. PubMed ID: 31445874
[TBL] [Abstract][Full Text] [Related]
19. Collection and sterilization of large volumes of bovine serum and its use in vaccines against bovine babesiosis and anaplasmosis.
Rodwell BJ; Timms P; Parker RJ
Aust J Exp Biol Med Sci; 1980 Apr; 58(2):143-7. PubMed ID: 7436873
[TBL] [Abstract][Full Text] [Related]
20. Overcoming constraints to meeting increased demand for Babesia bigemina vaccine in Australia.
Standfast NF; Bock RE; Wiecek MM; deVos AJ; Jorgensen WK; Kingston TG
Vet Parasitol; 2003 Jul; 115(3):213-22. PubMed ID: 12935736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
